clofazimine - CISMeF

Preferred Label : clofazimine;

MeSH definition : A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619);

MeSH synonym : n,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine;

MeSH hyponym : B-663; lamprene; G-30,320; B 663; B663; G 30,320; G30,320;

MeSH CAS label : 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-;

MeSH Related Number : 2030-63-9 (Clofazimine);

Registry Number MeSH : 2030-63-9;

Wikipedia link : https://en.wikipedia.org/wiki/Clofazimine;

Codes EINECS : 217-980-2;

Is substance : O;

UNII : D959AE5USF;

InChIKey : WDQPAMHFFCXSNU-BGABXYSRSA-N;

Details

Origin ID

D002991;

UMLS CUI

C0008996;

ATC code(s)
- clofazimine [ATC Code]
- dapsone, rifampicin and clofazimine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Clofazimine adverse reaction (disorder) [SNOMED CT concept]
- clofazimine [Substance BNPC]
Currated CISMeF NLP mapping
- Clofazimine [ICD-11 Extension code]
- Clofazimine [LOINC component]
- Clofazimine [ICHI extension code]
- Clofazimine [SMS substance]
- Clofazimine [NCIt concept]
- Clofazimine (substance) [SNOMED CT concept]
- clofazimine [SNOMED Notion]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
- leprostatic agents [MeSH Descriptor]
Record concept(s)
- B-663 [MeSH concept]
- G-30,320 [MeSH concept]
- clofazimine [MeSH concept]
- lamprene [MeSH concept]
Related MeSH Supplementary Concept(s)
- 3-(4-hydroxyanilino)-10-(4-chlorophenyl)-2,10-dihydro-2-isopropyliminophenazine [MeSH Supplementary Concept]
- 3-(beta-D-glucopyranosiduronic acid)-10-(4-chlorophenyl)-2,10-dihydro-2-isopropyliminophenazine [MeSH Supplementary Concept]
- B 1056 [MeSH Supplementary Concept]
- B 4121 [MeSH Supplementary Concept]
- B 4154 [MeSH Supplementary Concept]
- B 4157 [MeSH Supplementary Concept]
- B 669 [MeSH Supplementary Concept]
- B 746 [MeSH Supplementary Concept]
- B 749 [MeSH Supplementary Concept]
- B 775 [MeSH Supplementary Concept]
- B1912 [MeSH Supplementary Concept]
Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Clofazimine [ICD-11 Extension code]
- Clofazimine [NCIt concept]
- Clofazimine [LOINC component]
- Clofazimine (substance) [SNOMED CT concept]
- Product containing clofazimine (medicinal product) [SNOMED CT concept]
- clofazimine [ATC Code]
- clofazimine [Substance BNPC]
- clofazimine [SNOMED Notion]
Validated automatic mappings to BTNT
- clofazimine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients